Daniell Richard
EVP, Europe Commercial
Daniell Richard has filed 5 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: May 7, 2026.
On the most recent filing, Daniell Richard is listed as EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD. Inside the rolling window, Daniell Richard reported no open-market purchases and 5 open-market sales totaling $12.1M in TEVA. The largest disclosed transaction in the window is a sale of 128,985 TEVA shares on Mar 3, 2026, worth $4.2M.
Companies traded
Other insiders at TEVA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$12.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Daniell Richard made?
Daniell Richard has filed 5 SEC Form 4 filings (15 transaction rows) across 1 company since 2025.
Which companies does Daniell Richard trade?
Daniell Richard has filed SEC Form 4 disclosures for 1 company, including TEVA.
When was Daniell Richard's most recent SEC Form 4 filing?
Daniell Richard's most recent SEC Form 4 filing on Tracefour is dated May 7, 2026.
What is Daniell Richard's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Daniell Richard is listed as EVP, Europe Commercial.
What is Daniell Richard's total buy and sell value in the current window?
Inside the rolling retention window, Daniell Richard bought $0 and sold $12.1M based on SEC Form 4 filings.
What was Daniell Richard's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 128,985 TEVA shares on 2026-03-03, worth $4.2M, per SEC Form 4 filings.